1412PHLA-DrbB1 heterozygosis and early auto-antibody rise predict prolonged survival in metastatic NSCLC patients undergoing PD-1 blockade. (23rd October 2018) - Correale, P; Giannicola, R; Botta, C; Tagliaferri, P S; Pastina, P; Monoriti, M; Saladino, R; Falzea, A; Barbieri, V; D'Arrigo, G; Tripepi, G; Tassone, P; et al.